Nitroglycerin in difficult-to-wean COPD patients?

Both experimental and clinical data give convincing evidence to acute cardiac dysfunction as the origin or a cofactor of weaning failure in patients with chronic obstructive pulmonary disease. Therefore, treatment targeting the cardiovascular system might help the heart to tolerate more effectively the critical period of weaning. This study aims to assess the hemodynamic, respiratory and clinical effects of nitroglycerin infusion in difficult-to-wean patients with severe chronic obstructive pulmonary disease.

Methods Twelve difficult-to-wean (failed [greater than or equal to] 3 consecutive trials) chronic obstructive pulmonary disease patients, who presented systemic arterial hypertension (systolic blood pressure [greater than or equal to] 140mmHg) during weaning failure, and had systemic and pulmonary artery catheters in place participated in this prospective, interventional, non-randomized clinical trial. Patients were studied in two consecutive days, i.e., the first day without (Control day) and the second day with (Study day) nitroglycerin continuous intravenous infusion starting at the beginning of the spontaneous breathing trial, and titrated to maintain normal systolic blood pressure. Hemodynamic, oxygenation and respiratory measurements were performed on mechanical ventilation, and during a 2-hour T-piece spontaneous breathing trial. Primary endpoint was hemodynamic and respiratory effects of nitroglycerin infusion. Secondary endpoint was spontaneous breathing trial and extubation outcome.

Results

• Compared to mechanical ventilation, mean systemic arterial pressure, rate-pressure product, mean pulmonary arterial pressure, and pulmonary artery occlusion pressure increased [from (mean+/-SD) 94+/-14, 13708+/-3166, 29.9+/-4.8, and 14.8+/-3.8 to 109+/-20mmHg, 19856+/-4877mmHg b/min, 41.6+/-5.8mmHg, and 23.4+/-7.4 mmHg, respectively], and mixed venous oxygen saturation decreased (from 75.7+/-3.5 to 69.3 +/- 7.5%) during failing trials on Control day, whereas they did not change on Study day.
• Venous admixture increased throughout the trial on both Control day and Study day, but this increase was lower on Study day.
• Whereas weaning failed in all patients on Control day, nitroglycerine administration on Study day enabled a successful spontaneous breathing trial and extubation in 92% and 88% of patients, respectively.

Conclusions In this clinical setting, nitroglycerin infusion can expedite the weaning by restoring weaning-induced cardiovascular compromise.

Nitroglycerin can facilitate weaning of difficult-to-wean COPD patients: a prospective interventional non-randomized study - Critical Care 2010, 14:R204